CRISPR Therapeutics (CRSP) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-2.4
-1.99
-1.58
-1.16

Details

Expected EPS
-1.162892
Actual EPS
-1.37
Surprise EPS
-0.21
Surprise Percent
-17.81%

Description

⁨CRISPR Therapeutics⁩ (⁦CRSP⁩) has reported earnings of ⁦-1.37⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts